Susana Rodrigues: The Silent Safety Net Behind Every Transfusion
Susana Rodrigues, Clinical Lead for Blood Transfusion and Point of Care at KIMS Hospital, posted on LinkedIn:
”The Silent Safety Net Behind Every Transfusion
Blood transfusion is one of those areas in healthcare where nothing can ever be ‘good enough’.
It’s a high-risk, high-stakes process – and yet the safest outcomes rely on dozens of quiet, meticulous steps that most people never see.
Behind every unit transfused safely, there’s a whole framework at work:
- Human factors – understanding where people get distracted, pressured, or fatigued
- Risk reduction – building systems that prevent errors before they reach a patient
- Competency and confidence – making sure staff aren’t just trained once, but supported continuously
- Traceability – every unit, every step, every handover documented and aligned
- Collaboration – nursing, labs, porters, theatres, recovery… it’s never one person’s job.
Safe transfusion doesn’t happen by chance.
It happens because teams commit to following processes even when they’re busy, tired or under pressure – and because leaders keep safety visible, consistent, and non-negotiable.
For me, strong leadership in transfusion means:
• Calling out small risks before they become big ones
• Empowering staff to speak up when something feels off
• Making education practical, not overwhelming
• Creating a culture where safety is part of the identity, not a checklist.
When it’s done well, no one notices.
When it goes wrong, everyone does.
That’s why the silent work matters.
And why transfusion safety will always need champions, structure and leadership at every level.”

Stay updated with Hemostasis Today.
-
Aug 11, 2026, 16:44The Evolving Treatment Landscape of Hemophilia: From Factor Replacement to Gene Therapy
-
Aug 11, 2026, 16:34Advancing Hemophilia Care Through Training and Local Capacity Building – WFH
-
Aug 11, 2026, 16:26Sabrina H.: The Spectrum of PF4-Mediated Thrombotic Disorders
-
Aug 11, 2026, 16:17Mandy Lauw: From CRTH Training to Clinical Trials
-
Aug 11, 2026, 16:05Obi Light Ogbonnia: From 52 Years of Living With Sickle Cell to a Global Stage
-
Aug 11, 2026, 15:42Iva Pruner: Hemostasis, Thrombosis, and a Little Death Metal
-
Aug 11, 2026, 15:25Bradley Maron։ The AI Revolution in Cardiovascular Drug Development
-
Aug 11, 2026, 15:10Jared Rice: When a Negative DAT Doesn’t Mean the Alloimmune Risk Is Gone
-
Aug 11, 2026, 14:58Manuel De Jesus: Validating the Future of Point-of-Care Anemia Monitoring